Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
about
DNA immunization as a technology platform for monoclonal antibody inductionContrasting Adult and Infant Immune Responses to HIV Infection and VaccinationMeasurements of immune responses for establishing correlates of vaccine protection against HIVMucosal vaccines against respiratory syncytial virusThe influence of delivery vectors on HIV vaccine efficacyPotent and broad neutralization of HIV-1 by a llama antibody elicited by immunization.HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile.Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity.CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors.Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate.Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodiesTwo closely related Env antigens from the same patient elicited different spectra of neutralizing antibodies against heterologous HIV-1 isolates.Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding siteA critical question for HIV vaccine development: which antibodies to induce?Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFLNeutralizing antibodies to HIV-1 induced by immunization.Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk.Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates.Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.DNA immunization.DNA Immunization for HIV Vaccine Development.Increased, durable B-cell and ADCC Responses Associated with T-helper Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer.A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines.A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design.Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.
P2860
Q26751432-EA02B290-0092-4AD5-A553-CE31FE1A57E4Q26776518-4B8FFFA5-A9D2-4A27-A847-4DBAB616C93BQ28728189-CA6071E9-8732-4494-B79A-FC614A01A61EQ33837530-290946C1-D257-4D54-974E-E2A442726FCFQ34077543-463E52CA-6359-497F-BD6F-536ECA410024Q34284855-5040059F-E2B3-45B3-8EB9-C3E1276C15CEQ34399542-C1F57B40-B6C3-4D87-BFC8-4E77B4A176CAQ34499013-36AC78AA-7B29-4D2A-88FE-0BDA90E0A2D2Q34545420-1B453BF9-3004-4278-BA08-8B3E6B57E133Q34551010-65B1D165-5B01-4082-AAA2-1DEF719D8FDAQ34982715-A2401642-98C9-4476-8F87-7B6BC9210066Q35076664-3FB3A275-94A2-42B8-BFA5-AD8E0DEF7251Q35774051-6A9D4C06-0211-43FF-B9D6-F3ED49B8C55DQ35783015-5F9E731C-6FA8-4839-BC7E-5593C442D8B7Q35826610-E32C6E7C-4F85-4AA2-8F2A-A87B8236F947Q35883032-639F2FBE-B736-47DC-B658-3B8C2C2C0677Q35913910-0F994939-018E-4D57-93A8-96D623214050Q36603515-75C5E5E2-EA19-49A7-95BF-F0840021AA8FQ36911772-0B9103D2-07E3-4405-8FFD-6D831EA5F23BQ37336704-CDE5047D-5301-4F2C-A04A-2F2AAB925516Q37499531-81A56216-B13F-411E-B784-27850C82DEE8Q37576264-5D0A04C2-725F-419C-B250-3E087F4C9004Q38581981-42E75FD3-84C3-4444-88B6-8567FC50726EQ38658529-EEA54953-2C8F-498F-8A06-0361E632265EQ38725480-7A7E933A-FEEF-458C-82DE-E0DE8D670920Q40294097-DA4DEB13-B88D-451F-80E3-ED170791D80EQ41819464-FBA3AD27-43D5-4788-9ED8-D20DC68427E3Q41933070-D8445B32-9224-4FC0-AC92-FE9DD1C5EDBF
P2860
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Profiles of human serum antibo ...... on of Env-specific antibodies.
@ast
Profiles of human serum antibo ...... on of Env-specific antibodies.
@en
type
label
Profiles of human serum antibo ...... on of Env-specific antibodies.
@ast
Profiles of human serum antibo ...... on of Env-specific antibodies.
@en
prefLabel
Profiles of human serum antibo ...... on of Env-specific antibodies.
@ast
Profiles of human serum antibo ...... on of Env-specific antibodies.
@en
P2093
P2860
P50
P1433
P1476
Profiles of human serum antibo ...... on of Env-specific antibodies.
@en
P2093
James Arthos
Michael Vaine
Paul Goepfert
Shixia Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0013916
P407
P577
2010-11-09T00:00:00Z